Free Trial

Trading of BioSig Technologies was halted at 09:34 AM EST due to "LULD pause".

NASDAQ:BSGM

BioSig Technologies (BSGM) Stock Price, News & Analysis

BioSig Technologies logo
$6.41 +1.13 (+21.40%)
Closing price 04:00 PM Eastern
Extended Trading
$6.32 -0.09 (-1.33%)
As of 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About BioSig Technologies Stock (NASDAQ:BSGM)

Key Stats

Today's Range
$4.21
$6.84
50-Day Range
$0.48
$5.28
52-Week Range
$0.20
$7.36
Volume
1.96 million shs
Average Volume
286,404 shs
Market Capitalization
$174.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50
Consensus Rating
Buy

Company Overview

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BioSig Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

BSGM MarketRank™: 

BioSig Technologies scored higher than 14% of companies evaluated by MarketBeat, and ranked 870th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    BioSig Technologies has only been the subject of 1 research reports in the past 90 days.

  • Read more about BioSig Technologies' stock forecast and price target.
  • Short Interest

    There is no current short interest data available for BSGM.
  • Dividend Yield

    BioSig Technologies does not currently pay a dividend.

  • Dividend Growth

    BioSig Technologies does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for BSGM.
  • News Sentiment

    BioSig Technologies has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for BioSig Technologies this week, compared to 0 articles on an average week.
  • Search Interest

    62 people have searched for BSGM on MarketBeat in the last 30 days. This is an increase of 3,000% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added BioSig Technologies to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, BioSig Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.03% of the stock of BioSig Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.16% of the stock of BioSig Technologies is held by institutions.

  • Read more about BioSig Technologies' insider trading history.
Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

BSGM Stock News Headlines

Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
BioSig Technologies (BSGM) to Release Earnings on Monday
See More Headlines

BSGM Stock Analysis - Frequently Asked Questions

BioSig Technologies' stock was trading at $1.49 at the beginning of 2025. Since then, BSGM stock has increased by 330.2% and is now trading at $6.41.
View the best growth stocks for 2025 here
.

BioSig Technologies, Inc. (NASDAQ:BSGM) released its earnings results on Monday, May, 19th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.09.

BioSig Technologies's stock reverse split before market open on Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

BioSig Technologies' top institutional investors include Legacy Wealth Managment LLC ID (25.63%), Cambridge Investment Research Advisors Inc. (1.55%) and PFG Investments LLC (0.92%). Insiders that own company stock include Kenneth L Londoner, Steve Chaussy, Patrick Joseph Gallagher, John Sieckhaus and Gray Fleming.
View institutional ownership trends
.

Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioSig Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Citius Pharmaceuticals (CTXR), Roku (ROKU) and Ford Motor (F).

Company Calendar

Last Earnings
5/19/2025
Today
5/27/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BSGM
Fax
N/A
Employees
50
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.50
High Stock Price Target
$2.50
Low Stock Price Target
$2.50
Potential Upside/Downside
-57.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-29,040,000.00
Net Margins
-44,832.50%
Pretax Margin
-39,405.12%

Debt

Sales & Book Value

Annual Sales
$26,000.00
Price / Cash Flow
N/A
Book Value
($0.33) per share
Price / Book
-17.70

Miscellaneous

Free Float
14,300,000
Market Cap
$159.40 million
Optionable
No Data
Beta
0.02
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:BSGM) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners